Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-08-07 00:09 | 2014-08-05 | MMM | 3M CO | THULIN INGE G | Director, Officer | OPT+S | $139.49 | 13,749 | $1,917,847 | 116,129 |
| 2014-08-07 03:02 | 2014-08-04 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $49.12 | 5,000 | $245,617 | 69,207 |
| 2014-08-07 01:51 | 2014-08-06 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $57.77 | 4,300 | $248,424 | 450,235 |
| 2014-08-05 17:38 | 2014-08-01 | SYK | STRYKER CORP | Benscoter Steven P | Officer | OPT+S | $79.97 | 12,000 | $959,666 | 8,742 |
| 2014-08-05 17:37 | 2014-08-04 | SYK | STRYKER CORP | Owen Katherine Ann | Officer | OPT+S | $80.25 | 20,625 | $1,655,074 | 13,519 |
| 2014-08-06 00:52 | 2014-08-01 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $48.95 | 8,000 | $391,590 | 97,271 |
| 2014-08-05 18:31 | 2014-08-01 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $80.31 | 21,000 | $1,686,588 | 10,916,682 |
| 2014-08-05 23:07 | 2014-08-01 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | OGRADY JUDITH | Officer | SELL | $47.27 | 2,500 | $118,167 | 13,206 |
| 2014-08-06 02:59 | 2014-08-01 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $49.04 | 25,000 | $1,226,098 | 279,990 |
| 2014-08-05 23:13 | 2014-08-01 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | SELL | $12.58 | 10,000 | $125,817 | 287,855 |
| 2014-08-05 23:47 | 2014-08-04 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $11,750 | 1,393,631 |
| 2014-08-06 02:43 | 2014-08-01 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $34.23 | 20,000 | $684,672 | 257,184 |
| 2014-08-04 23:24 | 2014-08-01 | SYK | STRYKER CORP | Owen Katherine Ann | Officer | OPT+S | $79.97 | 35,000 | $2,799,076 | 13,519 |
| 2014-08-05 03:29 | 2014-08-01 | TNDM | TANDEM DIABETES CARE INC | Sheridan John F | Officer | OPT+S | $15.04 | 2,000 | $30,070 | 1,198 |
| 2014-08-04 20:57 | 2014-08-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $35.27 | 4,380 | $154,465 | 130,307 |
| 2014-08-05 01:03 | 2014-08-04 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $57.19 | 10,700 | $611,885 | 450,235 |
| 2014-08-01 22:48 | 2014-07-28 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 100,000 | $24,280 | 1,393,631 |
| 2014-08-01 22:45 | 2014-07-14 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $11,830 | 1,393,631 |
| 2014-07-31 23:35 | 2014-07-29 | MMM | 3M CO | Kelly Michael A | Officer | OPT+S | $145.20 | 11,418 | $1,657,837 | 2,719 |
| 2014-07-31 23:15 | 2014-07-29 | MMM | 3M CO | Shin Hak Cheol | Officer | OPT+S | $144.58 | 17,043 | $2,463,999 | 46,841 |
| 2014-07-31 22:19 | 2014-07-30 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $80.09 | 14,000 | $1,121,319 | 10,937,682 |
| 2014-07-31 23:37 | 2014-07-29 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | SELL | $47.76 | 50,800 | $2,426,208 | 956,809 |
| 2014-08-01 00:10 | 2014-07-29 | CRY | Artivion Inc. | RONALD C ELKINS | Director | SELL | $9.67 | 2,500 | $24,175 | 83,500 |
| 2014-07-30 23:20 | 2014-07-30 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | OPT+S | $12.97 | 157 | $2,036 | 43,161 |
| 2014-07-30 00:00 | 2014-07-28 | CRY | Artivion Inc. | ANDERSON STEVEN G | Officer | SELL | $9.52 | 19,477 | $185,501 | 1,366,333 |
| 2014-07-29 23:56 | 2014-07-28 | CRY | Artivion Inc. | Anderson Bruce G. | Officer | OPT+S | $9.48 | 5,000 | $47,424 | 35,564 |
| 2014-07-29 22:09 | 2014-07-01 | VYCO | VYCOR MEDICAL INC | Bronsther Oscar | Director | SELL | $2.75 | 6,241 | $17,163 | 18,216 |
| 2014-07-29 21:51 | 2014-07-28 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $80.02 | 14,000 | $1,120,308 | 10,951,682 |
| 2014-07-30 02:07 | 2014-07-25 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $38.19 | 10,000 | $381,857 | 159,099 |
| 2014-07-28 23:22 | 2014-07-25 | BAX | BAXTER INTERNATIONAL INC | Shapazian Carole J | Director | SELL | $76.98 | 1,645 | $126,632 | 5,001 |
| 2014-07-28 23:24 | 2014-07-24 | BAX | BAXTER INTERNATIONAL INC | STALLKAMP THOMAS T | Director | OPT+S | $76.82 | 8,300 | $637,606 | 6,479 |
| 2014-07-25 18:34 | 2014-07-25 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $80.20 | 7,000 | $561,427 | 10,965,682 |
| 2014-07-24 22:22 | 2014-07-22 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $81.84 | 21,000 | $1,718,615 | 10,972,682 |
| 2014-07-24 23:04 | 2014-07-22 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | SELL | $47.80 | 27,819 | $1,329,704 | 1,007,609 |
| 2014-07-25 00:50 | 2014-07-23 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | OPT+S | $38.16 | 4,000 | $152,654 | 126,136 |
| 2014-07-25 00:49 | 2014-07-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $38.28 | 14,000 | $535,986 | 241,399 |
| 2014-07-23 16:35 | 2014-07-21 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $12,045 | 1,393,631 |
| 2014-07-23 01:54 | 2014-07-18 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $36.01 | 8,000 | $288,070 | 87,786 |
| 2014-07-21 18:06 | 2014-06-10 | BONE | Xtant Medical Holdings, Inc. | HOLMES DARREL LEE | Officer | SELL | $0.74 | 50,000 | $37,000 | 11,656 |
| 2014-07-21 18:59 | 2014-07-21 | IRMD | IRADIMED CORP | HAWKINS JAMES B | Director | BUY | $6.25 | 80,000 | $500,000 | 80,000 |
| 2014-07-21 23:20 | 2014-07-18 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $81.33 | 14,000 | $1,138,668 | 10,993,682 |
| 2014-07-18 00:52 | 2014-07-16 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $82.53 | 14,000 | $1,155,417 | 11,007,682 |
| 2014-07-18 00:35 | 2014-07-15 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $36.66 | 35,000 | $1,283,128 | 662,889 |
| 2014-07-17 02:36 | 2014-07-15 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $49.22 | 3,200 | $157,504 | 106,655 |
| 2014-07-16 23:11 | 2014-07-15 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | OPT+S | $13.04 | 67,500 | $879,998 | 127,486 |
| 2014-07-16 02:15 | 2014-07-14 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $82.77 | 14,000 | $1,158,849 | 11,021,682 |
| 2014-07-15 15:27 | 2014-07-10 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $0.24 | 50,000 | $11,830 | 1,393,631 |
| 2014-07-16 01:46 | 2014-07-14 | DXCM | DEXCOM INC | LISTER JOHN | Officer | OPT+S | $36.59 | 3,500 | $128,077 | 114,158 |
| 2014-07-16 01:45 | 2014-07-11 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $35.93 | 10,000 | $359,347 | 159,099 |
| 2014-07-14 20:33 | 2014-07-10 | MMSI | MERIT MEDICAL SYSTEMS INC | STANGER KENT W | Director, Officer | SELL | $14.76 | 6,000 | $88,562 | 702,836 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.